Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,332,190 papers from all fields of science
Search
Sign In
Create Free Account
Avosentan
Known as:
2-Pyridinesulfonamide, N-(6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl)-5-methyl-
, 5-methylpyridine-2-sulfonic acid (6-methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)pyrimidin-4-yl)amide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Pyridines
Pyrimidines
Narrower (1)
SPP301
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
DIABeTIC NePhROPAThy : NOvel meChANISmS AND TheRAPIeS IN 2010
Pritam Gupta
2012
Corpus ID: 28440183
Diabetic nephropathy is the most common cause of end stage renal failure. In addition to renin pathway, other bioactive molecules…
Expand
2007
2007
Pharmaceutical compositions using aliskiren and avosentan
シューマッハー，クリストフ
,
ツァック，クリスティアン
,
ハクスレー，アリス
,
バルタトゥ，オヴィデュー
2007
Corpus ID: 79632223
The present invention is allowed (i) SPP100 / aliskiren or a combination thereof and a pharmaceutically acceptable salt thereof…
Expand
2007
2007
A pharmaceutical composition comprising the aliskiren and avosentan
Кристоф Шумахер
,
Элис Хаксли
,
Кристиан Цаугг
,
Овидиу Балтату
2007
Corpus ID: 79902704
1. A pharmaceutical composition comprising (1) SPP100 / aliskiren or a pharmaceutically acceptable salt thereof, (2) SPP301…
Expand